Balaji Srinivasan: The Man Who Called COVID
The former Coinbase CTO sounded the alarm early about the virus. More broadly, he’s emerged as a prolific and perceptive thinker about the trust and knowledge problems crypto aims to solve.
Related News
Balaji Srinivasan, the CEO of 21 Inc. is said to be one of the potential candidates for the post of the Commissioner of US FDA. The use of Bitcoin and blockchain technology in the traditional industry sector has been increasing drastically in the recent days. The ever-increasing popularity of cryptocurrency has influenced few well-known personalities to shift from mainstream companies to the Bitcoin sector. Now the tide has turned, after the head of Bitcoin startup 21 Inc. Balaji Srinivasan met President-elect Donald Trump. Balaji Srinivasan is said to be one of the candidates considered....
Adam Back and Balaji Srinivasan discuss global Bitcoin adoption and the rate at which it is accelerating at a pace faster than many people expected.
When Balaji Srinivasan talks, people listen. As a co-founder of 21 Inc., the company that has raised more money in the cryptocurrency space than any, Srinivasan naturally gains attention when he talks about cryptocurrency’s future. He recently set off a volley of engaging comments when he tweeted about one of the most contentious cryptocurrency topics – private blockchain consortiums. Srinivasan tweeted that consortiums could be the limiting blockchain adoption since one of their primary purposes is to bring normally distrusting actors together. Private blockchains make more sense among....
President-elect Donald Trump has met bitcoin startup 21 Inc CEO Balaji S. Srinivasan, one of two contenders to lead the Food and Drug Administration (FDA). The surprising announcement came unexpectedly to both technology and bitcoin communities, mostly because of his contributions to Silicon Valley and to the field of technology. However, as Bitcoin Core contributor Peter Todd noted, Srinivasan was previously involved in the medical industry, leading DNA screening startup Counsyl and obtaining a degree at the Stanford university’s department of developmental biology. Sources reveal that....
21 Inc. founder Balaji Srinivasan is a finalist to lead Donald Trump’s Federal Drug Administration (FDA). After being announced as a pick for Trump’s FDA, the ardent transhumanist deleted not only his thousands of tweets, but also his Medium blog posts. Social Media Memory Hole. In his social media activity, the tech entrepreneur’s tweets were critical....